Zharp2-1 structure
|
Common Name | Zharp2-1 | ||
|---|---|---|---|---|
| CAS Number | 2772600-18-5 | Molecular Weight | 383.40 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H18N3O2PS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Zharp2-1Zharp2-1 is an oral effective RIPK2 inhibitor, highly associated with inflammatory bowel disease (IBD). Zharp2-1 blocker muramyl dipeptide (MDP) induces growth of mononuclear cells and induces inflammatory cell factor infection. Zharp2-1 attenuates MDP-induced small inguinal peritonitis, or ameliorates by DNBS-induced large inguinal conjunctivitis[1]. |
| Name | Zharp2-1 |
|---|
| Description | Zharp2-1 is an oral effective RIPK2 inhibitor, highly associated with inflammatory bowel disease (IBD). Zharp2-1 blocker muramyl dipeptide (MDP) induces growth of mononuclear cells and induces inflammatory cell factor infection. Zharp2-1 attenuates MDP-induced small inguinal peritonitis, or ameliorates by DNBS-induced large inguinal conjunctivitis[1]. |
|---|---|
| Related Catalog | |
| Target |
RIPK2[1] |
| References |
| Molecular Formula | C19H18N3O2PS |
|---|---|
| Molecular Weight | 383.40 |
| InChIKey | SCBFIYRRWCWQAT-UHFFFAOYSA-N |
| SMILES | COc1cc2nccc(Nc3ccc4scnc4c3)c2cc1P(C)(C)=O |